1. Home
  2. NEO
  3. NEO News

Latest NeoGenomics Inc. (NEO) News on February 23, 2025

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations
NEO

Simply Wall St.

4 days ago

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations

NEO

GuruFocus.com

4 days ago

NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

NEO

Thomson Reuters StreetEvents

4 days ago

Q4 2024 Neogenomics Inc Earnings Call

NEO

Argus Research

4 days ago

NEO: Lowering target price to $13.00

Why NeoGenomics (NEO) Shares Are Trading Lower Today
NEO

StockStory

5 days ago

Why NeoGenomics (NEO) Shares Are Trading Lower Today

NeoGenomics (NEO) Tops Q4 Earnings Estimates
NEO

Zacks

5 days ago

NeoGenomics (NEO) Tops Q4 Earnings Estimates

NEO

MT Newswires

5 days ago

NeoGenomics Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Drop Pre-Bell

NEO

Associated Press Finance

5 days ago

NeoGenomics: Q4 Earnings Snapshot

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets
NEO

StockStory

5 days ago

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
NEO

Business Wire

5 days ago

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
NEO

StockStory

6 days ago

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

NEO

Thomson Reuters StreetEvents

11 days ago

Q4 2024 Adaptive Biotechnologies Corp Earnings Call

NEO

Argus Research

18 days ago

NEO: Lowering target price to $15.00

NEO

MT Newswires

24 days ago

Pacific Biosciences of California Appoints NeoGenomics CEO to Board of Directors

PacBio Announces Appointment of Chris Smith to Board of Directors
NEO

GlobeNewswire

24 days ago

PacBio Announces Appointment of Chris Smith to Board of Directors

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
NEO

Business Wire

25 days ago

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

NEO

Argus Research

25 days ago

NEO: Raising target price to $16.00

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss
NEO

Simply Wall St.

a month ago

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss

NEO

Argus Research

a month ago

NEO: Raising target price to $15.00

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance
NEO

Investor's Business Daily

a month ago

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

NEO

MT Newswires

a month ago

NeoGenomics Provides 2025 Revenue Outlook

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
NEO

Business Wire

a month ago

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?
NEO

Zacks

a month ago

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

NEO

Argus Research

a month ago

NEO: Lowering target price to $14.00

NEO

MT Newswires

a month ago

Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
NEO

GlobeNewswire

a month ago

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

NEO

MT Newswires

a month ago

Benchmark Downgrades NeoGenomics to Hold From Buy

NEO

MT Newswires

a month ago

NeoGenomics Appoints Tony Zook as CEO

NeoGenomics Announces Chief Executive Officer Succession
NEO

Business Wire

a month ago

NeoGenomics Announces Chief Executive Officer Succession

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
NEO

Business Wire

2 months ago

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

NeoGenomics (NEO) Upgraded to Buy: Here's Why
NEO

Zacks

2 months ago

NeoGenomics (NEO) Upgraded to Buy: Here's Why

NEO

Argus Research

2 months ago

NEO: Lowering target price to $17.00

NEO

Argus Research

2 months ago

NEO: Rating increased to a HOLD

NEO

MT Newswires

2 months ago

Natera Expands Lawsuit Against NeoGenomics to Include Additional Patent

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
NEO

Business Wire

2 months ago

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

NEO

Argus Research

2 months ago

NEO: Raising target price to $17.00

NEO

MT Newswires

2 months ago

Jefferies Initiates NeoGenomics at Buy With $22 Price Target

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
NEO

Business Wire

2 months ago

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

NEO

Argus Research

3 months ago

NEO: Raising target price to $16.00

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
NEO

Business Wire

3 months ago

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Felicia Williams Joins NeoGenomics Board of Directors
NEO

Business Wire

3 months ago

Felicia Williams Joins NeoGenomics Board of Directors

NEO

Argus Research

3 months ago

NEO: Raising target price to $17.00

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
NEO

Business Wire

3 months ago

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should Know
NEO

Zacks

4 months ago

NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should Know

NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations
NEO

Simply Wall St.

4 months ago

NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations

NEO

Thomson Reuters StreetEvents

4 months ago

Q3 2024 Neogenomics Inc Earnings Call

NEO

GuruFocus.com

4 months ago

NeoGenomics Inc (NEO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

NEO

Argus Research

4 months ago

NEO: Raising target price to $16.00

NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say
NEO

Zacks

4 months ago

NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say

NEO

MT Newswires

4 months ago

NeoGenomics' Q3 Adjusted Earnings, Revenue Rise

NEO

Associated Press Finance

4 months ago

NeoGenomics: Q3 Earnings Snapshot

NeoGenomics Reports Third Quarter 2024 Results
NEO

Business Wire

4 months ago

NeoGenomics Reports Third Quarter 2024 Results

Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to Trade
NEO

Zacks

4 months ago

Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to Trade

NeoGenomics gains conditional approval for solid tumour assays in New York
NEO

Medical Device Network

4 months ago

NeoGenomics gains conditional approval for solid tumour assays in New York

NEO

MT Newswires

4 months ago

NeoGenomics Gets Conditional Approval for Cancer Tests in New York

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
NEO

Business Wire

4 months ago

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
NEO

Business Wire

4 months ago

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
NEO

Zacks

4 months ago

NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
NEO

Business Wire

4 months ago

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

NEO

MT Newswires

5 months ago

Update: Natera Says Court Orders Permanent Injunction Against NeoGenomics' RaDaR Assay

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
NEO

Business Wire

5 months ago

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

NEO

MT Newswires

5 months ago

Natera Says Court Orders Permanent Injunction Against NeoGenomics' RaDaR Assay

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
NEO

Business Wire

5 months ago

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
NEO

Business Wire

6 months ago

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

NEO

Argus Research

6 months ago

NEO: What does Argus have to say about NEO?

NEO

Argus Research

6 months ago

NEO: What does Argus have to say about NEO?

Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q2 Earnings
NEO

Zacks

7 months ago

Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q2 Earnings

NEO

MT Newswires

7 months ago

NeoGenomics Swings to Q2 Adjusted Profit, Revenue Increases; Raises 2024 Revenue Outlook

NEO

Associated Press Finance

7 months ago

NeoGenomics: Q2 Earnings Snapshot

NeoGenomics Reports Second Quarter 2024 Results
NEO

Business Wire

7 months ago

NeoGenomics Reports Second Quarter 2024 Results

NEO

Argus Research

7 months ago

NEO: Lowering target price to $12.00

NeoGenomics (NASDAQ:NEO) shareholders have endured a 68% loss from investing in the stock three years ago
NEO

Simply Wall St.

7 months ago

NeoGenomics (NASDAQ:NEO) shareholders have endured a 68% loss from investing in the stock three years ago

Is NeoGenomics, Inc. (NEO) the Most Profitable Stock of the Last 20 Years?
NEO

Insider Monkey

7 months ago

Is NeoGenomics, Inc. (NEO) the Most Profitable Stock of the Last 20 Years?

NEO

Argus Research

7 months ago

NEO: Raising target price to $13.00

NEO

Argus Research

7 months ago

NEO: What does Argus have to say about NEO?

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
NEO

Business Wire

7 months ago

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

NEO

Argus Research

8 months ago

NEO: Raising target price to $11.00

Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
NEO

Business Wire

8 months ago

Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
NEO

Business Wire

9 months ago

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management

NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript
NEO

Insider Monkey

10 months ago

NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript

NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
NEO

Simply Wall St.

10 months ago

NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

NEO

GuruFocus.com

10 months ago

NeoGenomics Inc (NEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...

NEO

MT Newswires

10 months ago

Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating

Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q1 Earnings
NEO

Zacks

10 months ago

Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q1 Earnings

NeoGenomics Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss Narrows
NEO

GuruFocus.com

10 months ago

NeoGenomics Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss Narrows

NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates
NEO

Zacks

10 months ago

NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates

NEO

Associated Press Finance

10 months ago

NeoGenomics: Q1 Earnings Snapshot

NeoGenomics Reports First Quarter 2024 Results
NEO

Business Wire

10 months ago

NeoGenomics Reports First Quarter 2024 Results

Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
NEO

Zacks

10 months ago

Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know

NEO

Argus Research

10 months ago

NEO: What does Argus have to say about NEO?

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
NEO

Zacks

10 months ago

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

NeoGenomics Announces Senior Leadership Promotions
NEO

Business Wire

10 months ago

NeoGenomics Announces Senior Leadership Promotions

Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
NEO

Zacks

10 months ago

Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
NEO

Business Wire

10 months ago

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
NEO

Business Wire

a year ago

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting

All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy
NEO

Zacks

a year ago

All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy

Does NeoGenomics (NEO) Have the Potential to Rally 43.34% as Wall Street Analysts Expect?
NEO

Zacks

a year ago

Does NeoGenomics (NEO) Have the Potential to Rally 43.34% as Wall Street Analysts Expect?

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
NEO

Business Wire

a year ago

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
NEO

Business Wire

a year ago

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference

Wall Street Analysts Predict a 29.57% Upside in NeoGenomics (NEO): Here's What You Should Know
NEO

Zacks

a year ago

Wall Street Analysts Predict a 29.57% Upside in NeoGenomics (NEO): Here's What You Should Know

Share on Social Networks: